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Available online 1 September 2015AbstractParachlamydia acanthamoebae is an obligate intracellular bacterium naturally infecting free-living amoebae. The role of this bacterium as an
agent of pneumonia is suggested by sero-epidemiological studies and molecular surveys. Furthermore, P. acanthamoebae may escape mac-
rophages microbicidal effectors. Recently, we demonstrated that intratracheal inoculation of P. acanthamoebae induced pneumonia in 100% of
infected mice. However, the intratracheal route of infection is not the natural way of infection and we therefore developed an intranasal murine
model.
Mice inoculated with P. acanthamoebae by intranasal inoculation lost 18% of their weight up to 8 days post-inoculation. All mice presented
histological signs of pneumonia at day 2, 4, 7, and 10 post-inoculation, whereas no control mice harboured signs of pneumonia. A 5-fold increase
in bacterial load was observed from day 0 to day 4 post-inoculation. Lungs of inoculated mice were positive by Parachlamydia-specific
immunohistochemistry 4 days post-inoculation, and P. acanthamoebae were localized within macrophages.
Thus, we demonstrated that P. acanthamoebae induce a severe pneumonia in mice. This animal model (i) further supports the role of P.
acanthamoebae as an agent of pneumonia, confirming the third Koch postulate, and (ii) identified alveolar macrophages as one of the initial cells
where P. acanthamoebae is localized following infection.
© 2015 The Authors. Published by Elsevier Masson SAS on behalf of Institut Pasteur. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Parachlamydia acanthamoebae is an obligate intracellular
Chlamydia-related bacteria belonging to the Chlamydiales
order. This bacteria was first isolated within amoebae during a
humidifier related fever outbreak in USA [1]. The researchers
investigating this outbreak also identified an association* Corresponding author. Center for Research on Intracellular Bacteria,
Institute of Microbiology, University Hospital Center and University of Lau-
sanne, 1011 Lausanne, Switzerland. Tel.: þ41 21 314 49 79; fax: þ41 21 314
40 60.
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).between the presence of anti-Parachlamydia antibodies and
pneumonia. This was the first hint in favour of a potential
pathogenic role of P. acanthamoebae in humans [1]. Then,
sero-epidemiological studies and molecular surveys provided
additional evidences of the role of P. acanthamoebae as an
agent of pneumonia (reviewed in Refs. [2,3]). For example,
presence of anti-Parachlamydia antibodies was associated
with aspiration pneumonia [4], whereas parachlamydial DNA
was amplified by PCR from patients with bronchiolitis or
community-acquired [5e8].
Noteworthy, P. acanthamoebae is able to (i) circumvent the
microbicidal effectors of the human macrophages, (ii) tonstitut Pasteur. This is an open access article under the CC BY-NC-ND license
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apoptosis [9,10]. In addition, P. acanthamoebae is able to
persists within pneumocytes and fibroblasts [11], making the
lung one likely target organ for infection following exposure
to P. acanthamoebae. Thus, P. acanthamoebae represents an
emerging agent of pneumonia, and an animal model is war-
ranted to confirm the 3rd and the 4th Koch postulates.
It was already demonstrated that intratracheal inoculation
of P. acanthamoebae induced a severe pneumonia in 100% of
infected mice [12]. However, the intra-tracheal route is not a
natural route of infection. Consequently, we developed a new
murine model of respiratory tract infection based on intranasal
inoculation.
2. Material and methods2.1. Bacterial strain and preparation of the inocula
Fig. 1. Intranasal inoculation of Parachlamydia acanthamoebae leads to mice
body weight loss. Body weight variation curves of C57BL/6 mice inoculated
with 2.5.108 living Parachlamydia acanthamoebae (triangle) or with the same
load of heat-inactivated bacteria (square).P. acanthamoebae strain Hall's coccus was grown in
amoebae and purified as described [11]. Such amoebal co-
culture is not permissive to Mycoplasma [13], excluding
then any risk of Mycoplasma contamination. Concentration of
living P. acanthamoebae in PBS was determined as described
[12]. Bacteria used as a negative control were heat-inactivated
during one hour at 90 C. Mock control was prepared by the
same purification process except that the amoebae were not
infected with P. acanthamoebae.2.2. Experimental model of infectionFourteen mice were inoculated intranasally as previously
described [14], with 2.5  108 living and heat-inactivated
Parachlamydia, respectively. Groups of 2 mice were sacri-
ficed at days 0, 2, 4, 7, 10, 14, and 21 days post-inoculation
(n ¼ 14 for each group). The right and left lung, as well as
the spleen, were aseptically removed and divided in five equal
parts for further investigations (see below). A blood sample
for serology was obtained at the time of the sacrifice. Mice
inoculated with PBS (n ¼ 4) were used as negative controls
and sacrificed 7 and 21 days post-inoculation. An additional
negative control was performed using a mock preparation and
mice (n ¼ 2) were sacrificed 7 days post-inoculation. All
animal experiments were approved by the Local District
Government and carried out in adherence to German regu-
lations for protection of animal life (permit: 33.42502-05/
940).2.3. HistopathologyFig. 2. Bacterial load in lungs of mice infected with Parachlamydia acan-
thamoebae. Quantification of the bacterial load in the lungs of mice inoculated
with living P. acanthamoebae (black square) compared to mice inoculated
with heat-inactivated bacteria (grey circle). P-value <0.01 and P-value<0.05
are depicted as ** and *, respectively.Lungs were fixed in 4% formalin buffer, paraffin
embedded, and stained with haematoxylin-eosin (H&E).
Stained sections were assessed for the type and degree of
pneumonia. Pneumonia was considered as interstitial when an
exudate composed of inflammatory cells was seen in the
alveolar interstitium, as alveolar or peribronchoalveolar when
the exudate was seen within the alveolar or peri-
bronchoalveolar space, and finally the pneumonia wasconsidered as confluent when the exudate was seen within
both interstitial and alveolar spaces.2.4. ImmunohistochemistryParaffin sections were investigated as already described
previously [15] for the presence of parachlamydial antigens by
using a specific polyclonal rabbit anti-Parachlamydia antibody
raised against purified elementary bodies, and for the presence
of macrophages using a monoclonal rat anti mouse F4/80
antibody (Catlag Medsystems, Buckingham, UK), according
to manufacturer's instructions.
757L. Pilloux et al. / Microbes and Infection 17 (2015) 755e7602.5. Real-time PCR assayParachlamydial DNA was extracted from the lungs using
the AquaPure Genomic DNA extraction Kit (BioRad Labo-
ratories, Rheinach, Switzerland) according to the manufac-
turer's instructions. Real-time PCR was performed as
described previously [16], to quantify the number of para-
chlamydial 16S rRNA gene copies.2.6. Amoebal co-cultureLungs were homogenized in a mortar and suspended in
PBS. Tissue suspension was processed as described previously
for amoebal co-culture [13]. Briefly, samples were inoculated
on Acanthamoeba castellanii seeded in 24-well microplates
(Corning, NY, USA), centrifuged at 1790  g, and incubated
at 32 C. Each well was screened daily for amoebal lysis and
after 6 days of subculture, the presence of P. acanthamoebaeFig. 3. Lung lesions and inflammation induced by intranasal inoculation of Parachl
different time post inoculation of Parachlamydia acanthamoebae. C) Inflammation
acanthamoebae. E) Type of cells infiltrated in lungs of mice at different time post i
mock controls.in all amoebal co-cultures was tested using a specific real-time
quantitative PCR as previously described [16].2.7. SerologyTwo-fold diluted mice sera were tested by immunofluo-
rescence for antibody reactivity against purified P. acantha-
moebae as previously described [17]. Fluorescein
isothiocyanate-coupled (FITC) anti-mouse immunoglobulin
antibody (BioRad) was used as a secondary antibody.2.8. Statistical analysisThe t-test was used to compare the genomic copies/5 ml
between mice infected with living P. acanthamoebae and mice
inoculated with heat-inactivated bacteria. Statistical analyses
were performed with GraphPad (GraphPad Software, San
Diego, CA, USA).amydia acanthamoebae. A) Degree of extension of the lesions in mice lungs at
degrees in lungs of mice at different time post inoculation of Parachlamydia
noculation of Parachlamydia acanthamoebae. B), D), and F) are the respective
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acanthamoebae, mice lost 18% of their weight up to 9 days
post-inoculation. Then mice started to recover weight and
survived up to 21 days (Fig. 1). In contrast, mice inoculated
intranasally with heat-inactivated bacteria showed no weight
loss up to 21 days (Fig. 1).3.2. Bacterial load and bacterial viabilityIn both groups, no death was recorded. Then, we assessed
the bacterial load in the lungs by using a specific quantitative
real-time PCR, revealing 100% positive up to 21 days post-
inoculation in infected mice. At day 0, this bacterial load
was of 105 bacteria/5 ml of DNA, and it increased about 5
times up to 4 days post-inoculation. We also observed a low
bacterial load of about 102 bacteria/5 ml at 2 and 4 days post-
inoculation, within spleens of infected mice. Conversely,
bacterial load (determined as copies of genomic DNA) in
lungs of mice inoculated with heat-inactivated bacteria
decreased continually up to 21 days post-inoculation (Fig. 2).
To know if bacteria recovered from lungs were viable, we
inoculated amoebal cells using infected lung lysates, and weFig. 4. Lung histopathological damages induced by intranasal inoculation of Para
living P. acanthamoebae 10 days post-inoculation (magnification 100). Mouse pre
a mouse infected with living P. acanthamoebae 10 days post-inoculation (magnifi
macrophages. C) Lung histopathology of a mouse infected with living P. acanth
confluent pneumonia with monocytes, macrophages and neutrophils. D) Lung histwere able to isolate living P. acanthamoebae from lungs of
infected mice up to 14 days post-inoculation. Conversely, no P.
acanthamoebae were recovered from any lung taken from the
control mice (Data not shown).3.3. Histopathological lesionsIn all mice infected with viable P. acanthamoebae, lung
histopathology was characterized by focal to multifocal lesions
at day 2 and day 4 post-inoculation. These lesions were char-
acterized as interstitial to confluent pneumonia, with purulent
exudates composed of neutrophils. At that time, mice inocu-
lated with heat-inactivated bacteria presented few focal lesions
of interstitial pneumonia, with few macrophages. From day 7 to
day 21, lung histopathology was characterized by focal to
diffuse lesions of interstitial to confluent pneumonia, with
lymphocytes/plasmocytes exudates. At that time, interstitial and
alveolar pneumonia was observed in 3 of 16 lungs of mice
inoculated with heat-inactivated bacteria. Mock control mice
did not exhibit any signs of pneumonia (Figs. 3 and 4).3.4. Presence of P. acanthamoebae within the lesionsLungs of mice inoculated with living P. acanthamoebae
were positive for Parachlamydia-specific immunohistochem-
istry from day 0 to day 14 post-inoculation (Fig. 5A) with achlamydia acanthamoebae. A) Lung histopathology of a mouse infected with
senting an interstitial pneumonia with macrophages. B) Lung histopathology of
cation 100). Mouse presenting a confluent pneumonia with monocytes and
amoebae 2 days post-inoculation (magnification 100). Mouse presenting a
opathology of a mock control mouse (magnification 100).
Fig. 5. Parachlamydia acanthamoebae are associated with immune cells
within infected lungs. A) Positive immunohistochemical staining against
Parachlamydia acanthamoebae in the lung of a mouse infected with living P.
acanthamoebae, magnification 400. B) Positive immunohistochemical
staining against monocytes/macrophages in the lung of a mouse infected with
living P. acanthamoebae, magnification 400.
Fig. 6. Antibody response after intranasal inoculation of Parachlamydia
acanthamoebae. Serological titer of specific anti-Parachlamydia antibodies in
mice inoculated with Parachlamydia acanthamoebae (black dots), and mice
inoculated with heat inactivated bacteria (grey dots).
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larger amount at day 4). Interestingly, we could observe, on
adjacent paraffin sections, a colocation between P. acantha-
moebae and macrophages at day 7 post-inoculation (Fig. 5A
and B).3.5. Serological responseMice sera were tested by immunofluorescence for anti-
Parachlamydia antibody reactivity. Serology was negative
(antibody titer < 1/32) from day 0 to day 7 in mice inoculated
with living P. acanthamoebae. On day 10 and 14, positive
serology was observed in mice inoculated with living bacteria
(Fig. 6). Conversely, serology was negative from day 0 to day
14 in all mice inoculated with heat-inactivated bacteria. This
was somehow expected since a similar result was already
observed after intratracheal inoculation of heat-inactivated P.
acanthamoebae [12]. Moreover, no anti-Parachlamydia anti-
body was detected in PBS- or mock-inoculated controls.
4. Discussion
In the present work, we demonstrated that following
intranasal inoculation, P. acanthamoebae induce a severe
pneumonia in mice. This is in line with a previous murine
model showing that P. acanthamoebae may cause pneumonia
in 100% of mice after intratracheal inoculation [12]. Intranasalinoculation is less invasive and more relevant to natural res-
piratory tract infection. After inoculation of 2.5  108 bacte-
ria, we could recover about 105 bacteria in the lungs at early
time post infection, which actually should be considered as the
real infecting dose. Signs of lethargy and ruffled fur were
associated with a body weight loss of 18% of initial mice's
weight. This is similar to what has been described in murine
models of Chlamydia pneumoniae respiratory tract infections
[18,19].
Noteworthy, we observed an increase in the bacterial load
up to 7 days post-inoculation. Then, bacteria were progres-
sively cleared. Two time periods were associated with the
recruitment of different immune cells at the infection sites.
Thus, up to day 7, pneumonia was severe and infected lungs
were full of neutrophils. Then, from day 7 to day 21 post-
infection, there were many mononuclear infiltrates. This sug-
gests that P. acanthamoebae might stimulate migration of
neutrophils and monocytes, like Chlamydia pneumoniae [20].
Clearance of P. acanthamoebae was very slow as observed for
C. pneumoniae [19], or Chlamydia psittaci [21], in similar
mice models, and we observed a systemic dissemination since
bacterial DNA was detected in the spleen of infected mice up
to 7 days post-inoculation. Interestingly, between 14 and 21
days post-inoculation, we observed a persistence of para-
chlamydial DNA with 103 DNA copy number/5 ml in the
lungs. This DNA could correspond to residual DNA of dead
bacteria, or DNA from alive and persistent P. acanthamoebae.
The latter hypothesis is in accordance with the described,
in vitro and in vivo, persistence of other members of the
Chlamydiales order [22e24]. Moreover, the systemic
dissemination of P. acanthamoebae observed here, and the
documented role of P. acanthamoebae in bovine abortion
[15,17,25], suggest that the respiratory tract might be a pri-
mary route of infection for subsequent P. acanthamoebae
placenta infections.
Since P. acanthamoebae is emerging as a new pathogen of
medical and veterinary importance, this new murine model
might be very useful to characterize the pathogenesis of
760 L. Pilloux et al. / Microbes and Infection 17 (2015) 755e760infections due to P. acanthamoebae, and to assess the impact
of specific genetic background by using specific knockout
mice [26]. Finally, given the growing body of evidence sup-
porting the pathogenic role of P. acanthamoebae as an agent
of lung infections [27], the murine model we developed may
be useful to test in vivo the susceptibility of P. acanthamoebae
to antibiotics such as doxycycline and macrolides, which were
already identified to be effective in vitro [28].
Conflict of interest
The authors declare to have no conflict of interest.
Acknowledgments
We thank Sebastien Aeby for technical support. Research
of G. Greub's group is supported by the SNSF grant n141050,
that covers the salary of L. Pilloux.
References
[1] Birtles RJ, Rowbotham TJ, Storey C, Marrie TJ, Raoult D. Chlamydia-
like obligate parasite of free-living amoebae. Lancet 1997;349:925e6.
[2] Greub G, Raoult D. Parachlamydiaceae: potential emerging pathogens.
Emerg Infect Dis 2002;8:625e30. http://dx.doi.org/10.3201/
eid0806.010210.
[3] Corsaro D, Greub G. Pathogenic potential of novel Chlamydiae and
diagnostic approaches to infections due to these obligate intracellular
bacteria. Clin Microbiol Rev 2006;19:283e97. http://dx.doi.org/10.1128/
CMR.19.2.283-297.2006.
[4] Greub G, Boyadjiev I, La Scola B, Raoult D, Martin C. Serological hint
suggesting that Parachlamydiaceae are agents of pneumonia in poly-
traumatized intensive care patients. Ann N. YAcad Sci 2003;990:311e9.
[5] Ossewaarde JM, Meijer A. Molecular evidence for the existence of
additional members of the order Chlamydiales. Microbiology
1999;145(Pt 2):411e7.
[6] Corsaro D, Venditti D, Valassina M. New parachlamydial 16S rDNA
phylotypes detected in human clinical samples. Res Microbiol
2002;153:563e7.
[7] Corsaro D, Venditti D, Le Faou A, Guglielmetti P, Valassina M. A new
chlamydia-like 16S rDNA sequence from a clinical sample. Microbi-
ology 2001;147:515e6.
[8] Greub G, Berger P, Papazian L, Raoult D. Parachlamydiaceae as rare
agents of pneumonia. Emerg Infect Dis 2003;9:755e6. http://dx.doi.org/
10.3201/eid0906.020613.
[9] Greub G, Desnues B, Raoult D, Mege J-L. Lack of microbicidal response
in human macrophages infected with Parachlamydia acanthamoebae.
Microbes Infect 2005;7:714e9. http://dx.doi.org/10.1016/
j.micinf.2005.01.009.
[10] Greub G, Mege JL, Raoult D. Parachlamydia acanthamoeba enters and
multiplies within human macrophages and induces their apoptosis. Infect
Immun 2003;71:5979e85. http://dx.doi.org/10.1128/IAI.71.10.5979-
5985.2003.
[11] Casson N, Medico N, Bille J, Greub G. Parachlamydia acanthamoebae
enters and multiplies within pneumocytes and lung fibroblasts. Microbes
Infect 2006;8:1294e300. http://dx.doi.org/10.1016/j.micinf.2005.12.011.[12] Casson N, Entenza JM, Borel N, Pospischil A, Greub G. Murine model
of pneumonia caused by Parachlamydia acanthamoebae. Microb Pathog
2008;45:92e7. http://dx.doi.org/10.1016/j.micpath.2008.04.003.
[13] Jacquier N, Aeby S, Lienard J, Greub G. Discovery of new intracellular
pathogens by amoebal coculture and amoebal enrichment approaches. J
Vis Exp 2013:e51055. http://dx.doi.org/10.3791/51055.
[14] Sommer K, Njau F, Wittkop U, Thalmann J, Bartling G, Wagner A, et al.
Identification of high- and low-virulent strains of Chlamydia pneumoniae by
their characterization in a mouse pneumonia model. FEMS Immunol Med
Mic 2009;55:206e14. http://dx.doi.org/10.1111/j.1574-695X.2008.00503.x.
[15] Ruhl S, Casson N, Kaiser C, Thoma R, Pospischil A, Greub G, et al.
Evidence for Parachlamydia in bovine abortion. Vet Microbiol
2009;135:169e74. http://dx.doi.org/10.1016/j.vetmic.2008.09.049.
[16] Casson N, Posfay-Barbe KM, Gervaix A, Greub G. New diagnostic real-
time PCR for specific detection of Parachlamydia acanthamoebae DNA
in clinical samples. J Clin Microbiol 2008;46:1491e3. http://dx.doi.org/
10.1128/JCM.02302-07.
[17] Borel N, Ruhl S, Casson N, Kaiser C, Pospischil A, Greub G. Para-
chlamydia spp. and related Chlamydia-like organisms and bovine abor-
tion. Emerg Infect Dis 2007;13:1904e7. http://dx.doi.org/10.3201/
eid1312.070655.
[18] Chen W, Kuo C. A mouse model of pneumonitis induced by Chlamydia
trachomatis: morphologic, microbiologic, and immunologic studies. Am
J Pathol 1980;100:365e82.
[19] Yang ZP, Kuo CC, Grayston JT. A mouse model of Chlamydia pneu-
moniae strain TWAR pneumonitis. Infect Immun 1993;61:2037e40.
[20] Molestina RE, Miller RD, Ramirez JA, Summersgill JT. Infection of
human endothelial cells with Chlamydia pneumoniae stimulates trans-
endothelial migration of neutrophils and monocytes. Infect Immun
1999;67:1323e30.
[21] Dutow P, Fehlhaber B, Bode J, Laudeley R, Rheinheimer C, Glage S,
et al. The complement C3a receptor is critical in defense against Chla-
mydia psittaci in mouse lung infection and required for antibody and
optimal T cell response. J Infect Dis 2014;209:1269e78. http://
dx.doi.org/10.1093/infdis/jit640.
[22] Hogan RJ, Mathews SA, Mukhopadhyay S, Summersgill JT, Timms P.
Chlamydial persistence: beyond the biphasic paradigm. Infect Immun
2004;72:1843e55. http://dx.doi.org/10.1128/IAI.72.4.1843e1855.2004.
[23] Kebbi-Beghdadi C, Cisse O, Greub G. Permissivity of Vero cells, human
pneumocytes and human endometrial cells to Waddlia chondrophila.
Microbes Infect 2011;13:566e74. http://dx.doi.org/10.1016/
j.micinf.2011.01.020.
[24] Jacquier N, Frandi A, Pillonel T, Viollier P, Greub G. Cell wall pre-
cursors are required to organize the chlamydial division septum. Nat
Commun 2014;5:3578. http://dx.doi.org/10.1038/ncomms4578.
[25] Wheelhouse N, Howie F, Gidlow J, Greub G, Dagleish M, Longbottom D.
Involvement of Parachlamydia in bovine abortions in Scotland. Vet J
2012;193:586e8. http://dx.doi.org/10.1016/j.tvjl.2012.01.008.
[26] Roger T, Casson N, Croxatto A, Entenza JM, Pusztaszeri M, Akira S,
et al. Role of MyD88 and Toll-like receptors 2 and 4 in the sensing of
Parachlamydia acanthamoebae. Infect Immun 2010;78:5195e201.
http://dx.doi.org/10.1128/IAI.00786-10.
[27] Greub G. Parachlamydia acanthamoebae, an emerging agent of pneu-
monia. Clin Microbiol Infect 2009;15:18e28. http://dx.doi.org/10.1111/
j.1469-0691.2008.02633.x.
[28] Casson N, Greub G. Resistance of different Chlamydia-like organisms to
quinolones and mutations in the quinoline resistance-determining region
of the DNA gyrase A- and topoisomerase-encoding genes. Int J Anti-
microb Agents 2006;27:541e4. http://dx.doi.org/10.1016/
j.ijantimicag.2006.03.009.
